Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Issues And Trends In Healthcare Delivery System

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hybrid zeolitic imidazolate frameworks with catalytically active TO4 building blocks.

Angewandte Chemie (International ed. in English)·2010

Same author

Whiter matter abnormalities in medication-naive subjects with a single short-duration episode of major depressive disorder.

Psychiatry research·2010

Same author

A new comorbidity index: the health-related quality of life comorbidity index.

Journal of clinical epidemiology·2010

Same author

S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer.

International journal of biological sciences·2010

Same author

Nano-sized SnSbAgx alloy anodes prepared by reductive co-precipitation method used as lithium-ion battery materials.

Journal of nanoscience and nanotechnology·2010

Same author

Complementary diffusion tensor imaging study of the corpus callosum in patients with first-episode and chronic schizophrenia.

Journal of psychiatry & neuroscience : JPN·2010

Same journal

Predicting the risk of serious muscle disorders in individuals eligible for statin treatment in England: derivation and validation of a clinical prediction model.

The Lancet. Digital health·2026

Same journal

Ensuring the clinical impact of medical artificial intelligence.

The Lancet. Digital health·2026

Same journal

Precision medicine's inevitable trajectory toward rare-disease-sized cohorts: implications for machine learning and deep learning.

The Lancet. Digital health·2026

Same journal

Artificial intelligence-based retinal imaging for brain health assessment: a scoping review.

The Lancet. Digital health·2026

Same journal

Digital demands for chronic disease research and management.

The Lancet. Digital health·2026

Same journal

Large language models as experimental systems in human psychopathology: a modelling study.

The Lancet. Digital health·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 7, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Artificial intelligence in COVID-19 drug repurposing.

Yadi Zhou¹, Fei Wang², Jian Tang³

¹Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

The Lancet. Digital Health

|September 28, 2020

Summary

This summary is machine-generated.

Artificial intelligence (AI) accelerates drug repurposing for new diseases like COVID-19. AI and network medicine streamline therapeutic development, reducing timelines and costs for faster treatments.

More Related Videos

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Dec 7, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Area of Science:

Pharmacology
Computational Biology
Medical Informatics

Background:

Drug repurposing offers a cost-effective and time-efficient strategy for developing new treatments for emerging diseases.
The COVID-19 pandemic highlighted the urgent need for rapid therapeutic development.
Artificial intelligence (AI) and network medicine are powerful tools for analyzing complex biological data.

Purpose of the Study:

To provide guidelines on leveraging AI for accelerating drug repurposing.
To illustrate the application of AI in precision medicine for drug discovery.
To demonstrate how AI can expedite drug repurposing for COVID-19.

Main Methods:

Review of current AI methodologies applicable to drug repurposing.
Discussion of AI model implementation in precision medicine frameworks.
Case study analysis of AI-driven drug repurposing for COVID-19.

Main Results:

AI approaches are essential and formidable for efficient drug repurposing.
AI models can significantly accelerate the identification of potential drug candidates.
Network medicine integrated with AI enhances target identification and validation.

Conclusions:

AI-based tools provide a strong rationale for advancing drug repurposing efforts.
AI and network medicine are critical for expediting therapeutic development, especially during pandemics.
The integration of AI into drug repurposing pipelines promises to revolutionize medication development.